Upfront autologous hematopoietic stem cell transplantation consolidation for patients with aggressive B-cell lymphomas in first remission in the rituximab era: A systematic review and meta-analysis. [electronic resource]
Producer: 20200526Description: 4417-4425 p. digitalISSN:- 1097-0142
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Combined Modality Therapy
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Induction Chemotherapy
- Lymphoma, Large B-Cell, Diffuse -- diagnosis
- Prognosis
- Proportional Hazards Models
- Publication Bias
- Rituximab -- administration & dosage
- Transplantation, Autologous
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Meta-Analysis; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.